Dose Exploration Intramuscular/Intravenous Prophylaxis Pharmacokinetic Exposure Response Study
Clinical trial NCT05872958 · COMPLETED
Trial details
- NCT number
- NCT05872958
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-19
- Primary completion
- 2024-08-20
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.